Bromocriptine is ineffective in the treatment of chronic nonfluent aphasia

Acta Neurol Belg. 1995 Dec;95(4):235-8.


The effect of bromocriptine on chronic nonfluent aphasia was investigated in 4 patients suffering from a stroke 24 to 35 months before the onset of this study (average 29 months). Two patients had Broca, one had global and the other transcortical motor aphasia. CT-scans demonstrated anterior-posterior infarctions in 3 patients and anterior infarction in one. Bromocriptine was given initially at a dosage of 10 mg/day, and of 25 mg/day during the follow ups. By means of aphasia tests, bromocriptine was found to be ineffective for the treatment of any symptoms of chronic nonfluent aphasia.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antiparkinson Agents / therapeutic use*
  • Aphasia, Broca / drug therapy*
  • Bromocriptine / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Treatment Failure


  • Antiparkinson Agents
  • Bromocriptine